Risk Assessment of Hypoglycemia Induced by the Interaction between Repaglinide and Clopidogrel

Yan Kuo, Zhang Nan, Lu Hongliu, Yang Huijuan, Li Taoyuan, Xia Wenbin

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (7) : 768-775.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (7) : 768-775. DOI: 10.16153/j.1002-7777.2021.07.007
Adverse Reaction

Risk Assessment of Hypoglycemia Induced by the Interaction between Repaglinide and Clopidogrel

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(7): 768-775 https://doi.org/10.16153/j.1002-7777.2021.07.007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉